Navigation Links
AMERIGROUP Corporation to Present at the 2007 Credit Suisse Healthcare Conference on November 13
Date:11/5/2007

VIRGINIA BEACH, Va., Nov. 5 /PRNewswire-FirstCall/ -- AMERIGROUP Corporation (NYSE: AGP) today announced that it will participate in the 2007 Credit Suisse Healthcare Conference on November 13 in Phoenix, Arizona.

A live broadcast of the Company's presentation, which begins Tuesday, November 13 at 10:00 a.m. Eastern Time, can be accessed on AMERIGROUP's Web site, http://www.amerigroupcorp.com, on the investors' page. A replay will be available for 30 days, and can be accessed at the same Web address.

AMERIGROUP Corporation, headquartered in Virginia Beach, Virginia, improves healthcare access and quality for the financially vulnerable, seniors and people with disabilities by developing innovative managed health services for the public sector. Through its subsidiaries, AMERIGROUP Corporation serves more than 1.7 million people in the District of Columbia, Florida, Georgia, Maryland, New Jersey, New York, Ohio, South Carolina, Tennessee, Texas and Virginia. For more information, visit http://www.amerigroupcorp.com.

CONTACTS:

Investors: Julie Loftus Trudell

Senior Vice President, Investor Relations

AMERIGROUP Corporation

(757) 321-3597

News Media: Kent Jenkins Jr.

Senior Vice President, Communications

AMERIGROUP Corporation

(757) 518-3671


'/>"/>
SOURCE AMERIGROUP Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. AMERIGROUP to Acquire Memphis Health Plan
2. AMERIGROUP Corporation to Host Investor Day
3. AMERIGROUP Names Mary McCluskey, MD, Chief Medical Officer
4. AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States
5. AMERIGROUP Corporation to Discuss Third Quarter Earnings on October 25
6. AMERIGROUP to Participate in National Disability Mentoring Day
7. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
8. Brooke Franchise Corporation Announces Selected July Results
9. MedThink Communications Retained by NanoBio Corporation
10. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
11. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)...nversion achieves technology and sensor standardiz...d reduces costs, IRVINE, Calif., May 9 /PRNewswir...Masimo, the inventor of Pulse CO-Oximetry and,Meas...y, have announced the,completion of Saint Barnabas...Masimo SET pulse oximetry. The New Jersey-based ho...
(Date:5/9/2008)...Calif., May 9 /PRNewswire/ -- Claremont Insurance,... Cyntron Payroll Solutions,( http://www.cyntron.co...arket and sell payroll services through the employ...the selling power and service capability of,employ...urring revenue,stream for the broker and protectio...
(Date:5/9/2008)...y 9 /PRNewswire/ -- The U.S. Air Force has paid a ... by a baby during childbirth at,a military hospita...ement,payments to children who suffered brain dama...es, according to what Air Force attorneys told the...n September 4, 2004 at the U.S. Naval,Hospital, Ok...
(Date:5/9/2008)...Calif., May 9 /PRNewswire/ -- Dakim, Inc., announc...d,s most iconic figure in,health and fitness, has ...on behalf of the company,s [m]Power Cognitive Fitn...seniors fight against dementia., Dakim,s [m]Power...igned,to help seniors combat a decline in mental f...
Breaking Medicine News(10 mins):Health News:Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry 2Health News:Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry 3Health News:Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry 4Health News:Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry 5Health News:New Payroll Service Expands Selling Power and Service Capability of Employee Benefits Brokers 2Health News:U.S. Air Force Pays Record Amount for Baby Injured in Government Hospital 2Health News:Physical Fitness 'Godfather' Jack LaLanne Turns to Brain Fitness, Becoming Ambassador for Dakim's [m]Power System 2
...act of global warming has spurred international ac...an environmental observation system// for India. ...rch and economic development at Louisiana State Un...onal science team tasked with helping India, one o...
...nts of suicides and fratricides in the armed force...steps to "urgently" address the// issue. "The num...e a cause of concern and must be addressed urgentl...the five-day Army Commanders' Conference here. T...
...lood pressure and prostate problems has been found...ans with posttraumatic stress disorder (PTSD). "...effective for PTSD nightmares and sleep disruption...ive director of the mental health service at the V...
...ersity of Toronto is revealing biochemical process...sis and could one day pave the way for pharmaceuti...ice to test for proteins that play an important ro...echnology, iMYTH (or integrated membrane yeast-two...
Other Medicine News:Health News:US Professor Helping India Deal With Global Warming 2Health News:Antony Concerned Over Growing Suicide Rates in Armed Forces 2Health News:BP and Prostate Problems Drug Effective in Treating PTSD Nightmares 2Health News:BP and Prostate Problems Drug Effective in Treating PTSD Nightmares 3Health News:New Technology Reveals Proteins Responsible for Diseases 2
(Date:5/8/2008)...trated significant improvement in ADHD symptoms in... -- Shire plc (LSE: SHP,Nasdaq: SHPGY), the globa...nted the results of a phase III pivotal study in w... in Attention Deficit Hyperactivity,Disorder (ADHD...cy,endpoints., "Adults with ADHD often find it ch...
(Date:5/8/2008)...ovides "Blueprint" to Produce Therapeutic Proteins.../PRNewswire-USNewswire/ -- Using gene,therapy, pla...ins through,skin flaps placed on cancerous tumors ...e, according to a study in the May issue of Plasti...cal journal of the American,Society of Plastic Sur...
(Date:5/8/2008)...an-Kettering Cancer Center Investigators to Assess...n Cancer Patients -, BRISBANE, Calif., May 8 /PRN...he expansion of Phase 2 clinical trial programs fo...is is the third major clinical trial,of BSI-201 th...ing on,on-going trials in breast and brain cancer....
(Date:5/7/2008)...tudy to Evaluate Efficacy and Safety in Treating a...ess, LEVERKUSEN, Germany, MONTVILLE, New Jersey a...l/ -- Bayer HealthCare AG and Regeneron,Pharmaceut...the first patient,has been dosed in the VIEW 2 tri...nt program evaluating VEGF Trap-Eye for the treatm...
Breaking Medicine Technology:Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 3Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 4Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 5Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 2Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 3BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 2Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 3Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 4Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 5Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 6HealthSouth Announces Final Agreement on Previously Disclosed Settlement with Federal Government 8321 1HealthSouth Announces Final Agreement on Previously Disclosed Settlement with Federal Government 8321 2Statement from the Consumer Healthcare Products Association on Todays FDA Advisory Committee Meeting on the Efficacy of Phenylephrine in the 10 Mg Ora 8318 1Statement from the Consumer Healthcare Products Association on Todays FDA Advisory Committee Meeting on the Efficacy of Phenylephrine in the 10 Mg Ora 8318 2Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers 24100 Million Cut in FY 2008 Budget for Its 2217 1Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers 24100 Million Cut in FY 2008 Budget for Its 2217 2Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers 24100 Million Cut in FY 2008 Budget for Its 2217 3Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers 24100 Million Cut in FY 2008 Budget for Its 2217 4Workplace Flexibility Can Boost Healthy Behaviors 8315 1Workplace Flexibility Can Boost Healthy Behaviors 8315 2
...ague Against Rheumatism,(EULAR) Congress Demonstra...s With Rheumatoid Arthritis, LONDON, England; PHIL...ne 15, 2007 /PRNewswire-FirstCall/ -- GlaxoSmithKl...y positive primary,efficacy data (evaluated at 24 ...uropean Congress of Rheumatology (abstract,number:...
...ver Tamoxifen in,a Single Trial , LUTON, UK, Frid... of a single trial has demonstrated that survival ...ed by switching from,tamoxifen to anastrozole (Ari..., (ARNO 95) study, published online in The,Journal...l women,who have been taking tamoxifen as part of ...
Other Medicine Technology:GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 2GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 3GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 4GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 5Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 2Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 3Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 4Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 5
ELISA kit for Varicella-zoster IgG.
Inquire
The CALBIOTECH, INC. (CBI), Mumps IgM ELISA tests system is an enzyme linked immunosorbent assay (ELISA) for the detection of IgM class antibodies to Mumps in human serum or plasma.
...ntific Corporation announced the launch of the Ch...bi-directional cooled-tip catheter available in th...ysicians the benefits of cooled ablation technolog...n Scientific Blazer(R) catheter platform. ,Coole...
Medicine Products: